Research summary, original research, 2025

Evidence for the lack of an increase in DNA damage in occupational healthcare workers exposed to ionizing radiation: An indication of radiation safety

Aishwarya S, Dubagunta N, Nandhini K, Pattan S, Rangasami R, Srinivas SK, et al.. Journal of occupational and environmental hygiene. 2025

Read the original paper

In plain language

In 25 radiation-exposed healthcare workers with low recorded doses, DNA damage markers did not rise with dose and gamma-H2AX matched 21 unexposed colleagues, although micronucleus frequency was higher. This small biomarker study does not establish health outcomes.

At a glance

Type of study
Original research, Laboratory or biomarker study
Size
n = 46 participants (25 radiation-exposed healthcare workers, 21 controls)
Summary based on
the abstract

What it found

  • Micronucleus frequency was significantly higher in radiation-exposed healthcare workers than in controls.

    Key figures: 0.005 ± 0.002 vs 0.001 ± 0.001 (p < 0.0001)

  • Gamma-H2AX foci frequency did not differ between exposed healthcare workers and controls.

    Key figures: 0.04 ± 0.01 vs 0.05 ± 0.01 (p > 0.05)

  • Biomarkers correlated only weakly with cumulative registered thermoluminescent dosimeter (TLD) dose.

    Key figures: γ-H2AX R2=0.0123; MN R2= 0.0011; FDXR R2= 0.0006

  • FDXR expression was modestly higher in exposed healthcare workers.

    Key figures: 7% increase

  • Cumulative registered doses among exposed workers were low.

    Key figures: 0 to 21 mSv, mean 3.65 mSv

Limits to keep in mind

Small cross-sectional biomarker study (25 exposed, 21 controls) with low cumulative doses and unspecified occupational roles, setting and country. TLD records may not reflect true dose, and the authors note assay sensitivity may limit detection of effects.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.